The American Society of Echocardiography (ASE) has issued a statement on how centers may consider to reopen cardiac ultrasound services as hospitals begin resuming elective procedures and tests amid the COVID-19 (SARS-CoV-2) pandemic. #COVID19 #SARScov2 #ASE
May 22, 2020
When and How to Reopen Echocardiography Services During the COVID-19 Pandemic
May 21, 2020 — The American Society of Echocardiography (ASE) has issued a statement on how centers may consider to…
Read More
SCAI Announces 2020 Late-breaking Clinical Studies, featured clinical research sessions. #SCAI2020
May 21, 2020
SCAI Announces 2020 Late-breaking Clinical Studies
May 21, 2020 — Here is the list of late-breaking study presentations and links to articles about each of them from the…
Read More
Left, the Melody pulmonary valve was the first transcatheter valve to be approved by the FDA in the United States a decade ago. Right, the Harmony transcatheter valve is in trials and is designed to treat patients with RVOT anomalies who develop severe PR typically when a pervious repair fails. Both valves are used to treat congenital heart defects. #SCAI #SCAI2020
May 21, 2020
Medtronic Congenital Heart Transcatheter Valve Studies Show Strong Results in SCAI Late-breakers
May 21, 2020 — Two late-breaking clinical trials on trans catheter valves to treat congenital heart disease were…
Read More
Rash on the skin of a child who has COVID-19 related multi-system inflammatory syndrome (MIS-C). Image copyright Damien Bonnet, M.D., Ph.D., courtesy of the American Heart Association. Coronavirus is linked with this Kawasaki-like inflammatory disease in children. #MIS-C #COVID #COVIDinkids #COVIDinChildren
Dave Fornell, Editor
May 20, 2020
Kawasaki-like Inflammatory Disease Affects Children With COVID-19
A new, serious COVID-19 cardiovascular presentation emerged in late April and early May 2020 in the form of pediatric…
Read More
HRS 2020 Late-Breaking Clinical Trials in Electrophyiology
May 20, 2020
Heart Rhythm Society 2020 Late-Breaking Clinical Trials in Electrophysiology
May 20, 2020 — Here is the complete list of late-breaking clinical trials (LBCT)  and links to articles on all of them…
Read More
he Actus AcQMap EP 3-D mapping catheter used to speed electromapping and procedure times.
May 20, 2020
Biotronik Partners With Acutus Medical to Offer More Efficient Arrhythmia Diagnosis and Treatment
May 20, 2020 — Acutus Medical and Biotronik announced a new alliance to provide a comprehensive portfolio of…
Read More
PREDICT-AF trial showed first time there is extensive extracellular matrix remodeling. #HRS2020 #Heartrhythm2020. Marilyn Fornell
May 19, 2020
Heart Tissue Changes Can Predict Atrial Fibrillation Prior to Onset
May 19, 2020 — Structural changes of the atrium may occur long before the onset of atrial fibrillation (AF), and the…
Read More
Results of the Atrial Fibrosis Predicts Recurrent Stroke Or New Atrial Fibrillation In Patients With Embolic Stroke Of Undetermined Source - A Multi-Center Study at HRS 2020. #HRS2020 #Heartrhythm2020,
May 19, 2020
Atrial Fibrosis Predicts Recurrent Stroke or New AF Onset 
May 19, 2020 — Atrial disease has been implicated in embolic stroke of undetermined source (ESUS) and a late-breaking…
Read More
Thermedical, a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT), announced that it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Saline Enhanced Radiofrequency (SERF) Ablation system and Durablate catheter.
May 19, 2020
Thermedical SERF Ablation System Earns FDA Breakthrough Device Designation 
May 19, 2020 – Thermedical, a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT),…
Read More
A list of all the abnormalities the AI model classifies. This illustration only shows three representative leads (DII, V1 and V6).Fig. This is Figure 1 from the Nature Communications article.
May 19, 2020
AI Tool Allows Automated ECG Interpretation for Cardiac Diagnostics
May 19, 2020 — Artificial intelligence (AI) may be an aid to interpreting ECG results, helping healthcare staff to…
Read More
Mayo Clinic is using artificial intelligence EchoGo Core software from Ultromics to automatically analyize echocardiography images to assess the cardiac impact of COVID-19. The AI software is from Ultromics.
May 19, 2020
Mayo Clinic Uses Artificial Intelligence to Help Assess Cardiac Danger From COVID-19
May 19, 2020 — A joint U.K.-U.S. research team is applying a pioneering artificial intelligence (AI) system to…
Read More
Edwards Lifesciences Pascal Tricuspid Valve Transcatheter Repair System Approved in Europe
May 18, 2020
Edwards Pascal Tricuspid Valve Transcatheter Repair System Approved in Europe
May 18, 2020 — The Edwards Lifesciences Corp. Pascal tricuspid transcatheter valve repair (TTVR) system received…
Read More
Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or nil per os (NPO), as there are no current standardized fasting protocols, but the CHOWNOW study found patients do not need to fast and will have similar outcomes. #SCAI2020
May 18, 2020
Eating Prior to Cardiac Cath Noninferior to Fasting in CHOW NOW Study 
May 18, 2020 – Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or…
Read More
ISCHEMIA Trial: Patients With Intermediate Left Main Coronary Disease Have Worse Cardiovascular Events. #SCAI2020
May 17, 2020
ISCHEMIA Trial: Patients With Intermediate Left Main Coronary Disease Have Worse Cardiovascular Events
May 17, 2020 – A new study shows that when compared with patients without intermediate left main coronary artery…
Read More
CD34+ Stem Cell Therapy Improved Quality of Life in Patients with Microvascular Dysfunction. #SCAI2020
May 17, 2020
Stem Cell Therapy Improved Quality of Life in Patients with Microvascular Dysfunction
May 17, 2020 – Trial results presented today revealed a promising therapy for patients experiencing angina due to…
Read More
Icosapent Ethyl (Vascepa) significantly Reduces Revascularizations in Statin Patients in the REDUCE-IT REVASC analyses presented as a late-breaking study at SCAI 2020. Photo by Dave Fornell
May 17, 2020
Icosapent Ethyl Significantly Reduces Revascularizations in Statin Patients
May 17, 2020 – Patients with high lipid levels have an increased risk for ischemic events, despite statin therapy.…
Read More
The Boston Scientific Synergy stent uses a unique abluminal, bioresorbable drug-carrier polymer that dissolves after the vessel wall has healed months after the stent is implanted. Stent polymers have been implicated in cases of late-stent thrombosis, which required patients with DES to stay on dual antiplatelet therapy (DAPT). This study looked at using the device as a way to shorten DAPT duration. #SCAI2020
May 17, 2020
TWILIGHT Trial Substudy Examines Bioabsorbable Polymer vs. Durable Polymer Drug-Eluting Stents in High-Risk PCI
May 17, 2020 – A new study sought to reveal whether drug-eluting stents (DES) coated with bioabsorbable polymer (BP)…
Read More
Cindy Grines Becomes SCAI President in 2020. #SCAI2020
May 17, 2020
Cindy Grines Becomes SCAI President
May 17, 2020 — Cindy Grines, M.D., MSCAI, a world-renowned physician credited for pioneering percutaneous coronary…
Read More
The protocol chart for the LATIN STEMI telecardiology program.
May 15, 2020
Telemedicine-based Network Offers Remote Guidance to 100 Million STEMI Patients
May 15, 2020 – A groundbreaking trial recently examined the viability of telemedicine for remote guidance of a…
Read More
An OCT intracoronary image showing instent restenosis. The white spots in the vessel wall casting shadows are the stent struts. OCT image data might be used in the future to assess FFR to determine the severity of lesions and determine if they need to be stented.
May 15, 2020
OCT May be Able to Show FFR Without Need for Pressurewire
May 15, 2020 – A late-breaking study aimed to evaluate whether optical coherence tomography (OCT) can predict…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now